Stay updated on Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page now displays a new revision note 'Revision: v3.3.4' and the previous 'Revision: v3.3.3' note was removed.
    Difference
    0.1%
    Check dated 2026-01-14T03:02:11.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    A new 'Locations' section is added with Pennsylvania listed as a site. The page footer shows revision v3.3.3, and the earlier 'Pennsylvania Locations' entry and 'HHS Vulnerability Disclosure' have been removed.
    Difference
    0.2%
    Check dated 2025-12-23T17:17:19.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2 on the study page, with no observable changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T21:16:51.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Removal of the funding status notice about government operating status and potential processing delays.
    Difference
    0.4%
    Check dated 2025-11-17T18:42:10.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The study record shows termination due to slow enrollment and lack of efficacy, with results posted on 2022-10-20.
    Difference
    0.5%
    Check dated 2025-11-03T13:18:13.000Z thumbnail image
  8. Check
    101 days ago
    Change Detected
    Summary
    Upgrade notice with updated operating status info and a version bump from v3.1.0 to v3.2.0.
    Difference
    4%
    Check dated 2025-10-06T02:17:30.000Z thumbnail image

Stay in the know with updates to Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial page.